Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Net Income towards Common Stockholders of $32.8 million for Q1 2026, up 17.65% year-over-year from $27.9 million in Q1 2025, and down 40.72% quarter-over-quarter from $55.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Net Income towards Common Stockholders data on file, last reported at $32.8 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $32.8 million, up 17.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.8 million (up 17.65% YoY), and the FY2025 annual result was $162.8 million, up 29.34% from the prior year.
- Net Income towards Common Stockholders eased to $32.8 million in Q1 2026 per STVN's latest filing, from $55.4 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $109.3 million in Q3 2023 and troughed at $20.4 million in Q1 2024.
- A 5-year average of $57.2 million and a median of $51.6 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders tumbled 37.6% in 2024, then surged 49.84% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $49.4 million in 2022, then fell by 1.41% to $48.7 million in 2023, then grew by 6.08% to $51.6 million in 2024, then climbed by 7.22% to $55.4 million in 2025, then sank by 40.72% to $32.8 million in 2026.
- Business Quant data shows STVN's Net Income towards Common Stockholders at $32.8 million in Q1 2026, $55.4 million in Q4 2025, and $107.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 32.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.81 Mn |
| Dec 31, 2025 | 55.36 Mn |
| Sep 30, 2025 | 107.89 Mn |
| Jun 30, 2025 | 63.64 Mn |
| Mar 31, 2025 | 27.89 Mn |
| Dec 31, 2024 | 51.63 Mn |
| Sep 30, 2024 | 76.29 Mn |
| Jun 30, 2024 | 42.47 Mn |
| Mar 31, 2024 | 20.44 Mn |
| Dec 31, 2023 | 48.67 Mn |
| Sep 30, 2023 | 109.29 Mn |
| Jun 30, 2023 | 68.06 Mn |
| Mar 31, 2023 | 30.34 Mn |
| Dec 31, 2022 | 49.36 Mn |
| Sep 30, 2022 | 95.25 Mn |
| Jun 30, 2022 | 62.16 Mn |
| Mar 31, 2022 | 31.11 Mn |
| Dec 31, 2021 | 51.11 Mn |
| Sep 30, 2021 | 105.72 Mn |
| Jun 30, 2021 | 85.49 Mn |